Brief: Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents For Cancer Treatment

Shuttle Pharmaceuticals Holdings

15/09/2022 13:42

Sept 15 (Reuters) - Shuttle Pharmaceuticals Inc  SHPH.O :
    * SHUTTLE PHARMACEUTICALS AWARDED NEW HDAC INHIBITOR PATENTS
FOR
CANCER TREATMENT
    * SHUTTLE PHARMACEUTICALS INC - COMPANY AWARDED PATENTS IN
U.S.
AND HONG KONG
    * SHUTTLE PHARMACEUTICALS INC - HAS BEEN AWARDED PATENTS IN
U.S.
AND HONG KONG FOR ITS RADIATION SENSITIZING HDAC INHIBITOR
TECHNOLOGY PLATFORM

Source text for Eikon:  ID:nPn1MTRHpa 
Further company coverage:  SHPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))